Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,041.3
-79.3 (-2.54%)

 

  • STI Straits Times Index
    3,041.3
    -79.3 (-2.54%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,514.0
    3.4 (0.23%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,475.3
    -377.0 (-1.58%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,563.9
    1.2 (0.03%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,821.8
    -462.2 (-1.63%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,533.9
    -74.4 (-1.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,947.1M
  • Value: 3,865.3M
  • Rise: 100
  • Fall: 254
  • Unch: 403

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Lippo Malls Tr0.054-
Singtel2.360-0.050
Sembcorp Marine0.085+0.002
Genting Sing0.770-0.020
Medtecs Intl0.440-0.060
HGH0.020+0.001
ComfortDelGro1.370-0.060
CapLand IntCom T2.110-0.030
Ascendas Reit2.920-0.070
ThaiBev0.670-0.015

World Indices

World Indices
Name Last Change
Nasdaq 15,782.8 +291.2
HSI 23,475.3 -377.0
HSCEI 8,368.5 -129.8
Jakarta 6,533.9 -74.4
Nikkei 225 27,821.8 -462.2
SSE Comp 3,563.9 +1.2
Shanghai A 3,735.2 +1.3
Shanghai B 279.4 -1.1
KOSPI 2,839.0 -70.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

RESPIRI LTD RESPIRI LTD
Updated on 30 Nov 2021 (End of trading day)
Last (AUD): 0.059 Change: - High: 0.059 Remarks: -
Change (%): - Low: 0.059

Company Background

Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. The firm operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.

Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.01527 Trailing EPS (AUD) b -0.01527 NAV (AUD) c 0.0105
PE a - Trailing PE d - Price / NAV c 5.6190
Dividend Yield (%) e - Cash In Hand (AUD) f 0.0110 Issued & Paid-up Shares g 722,841,000
Piotroski F Score 2 Market Cap (M) 42.648 Free Float (%) 74.1
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i n.m.
Net Earnings Growth (%) j -52.051 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 18 Mar 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days --0.002
-3.28 %
Medium Term Return 3 Months --0.030
-33.71 %
6 Months --0.034
-36.56 %
1 Year --0.101
-63.12 %
Long Term Return 2 Years --0.021
-26.25 %
3 Years --0.031
-34.44 %
5 Years -+0.006
+11.32 %
Annualised Return Annualised --
+2.17 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference RESPIRI LTD ASX 42.648 - - 5.6190 -
Industry Medical Specialties ASX 2,165.796 66.814 64.632 10.7743 0.843
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 18,340.073 37.468 65.702 - 1.312
Local Peer COCHLEAR LTD ASX 14,325.817 43.877 43.877 8.4185 1.170
Local Peer EBOS GROUP ASX 5,746.545 31.013 31.013 4.0726 2.457
Local Peer NANOSONICS LIMITED ASX 1,647.277 192.051 192.035 12.1522 -
Local Peer INCANNEX HEALTHCARE LTD ASX 688.862 - - 80.2817 -
Local Peer METRICS INCOME OPPORTUNITIES TRUST ASX 614.786 - - -430.6122 -
Local Peer AROA BIOSURGERY LTD ASX 389.724 - - 7.2473 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 342.857 - - 5.0198 -
Local Peer IMPEDIMED LIMITED ASX 301.888 - - 11.8056 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 286.542 - - 4.6042 -
Local Peer CLARITY PHARMACEUTICALS LTD ASX 229.239 - - 11.3005 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 201.016 - - 20.0000 -
Other Local Peers SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), MICRO-X LTD (ASX), SDI LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), OPTISCAN IMAGING (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), CLEANSPACE HOLDINGS LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), DIMERIX LTD (ASX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), RESONANCE HEALTH LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), TRUSCREEN GROUP LTD (ASX), ADHERIUM LIMITED (ASX), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ANALYTICA (ASX)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 255,646.521 40.101 29.848 6.6041 0.137
Global Peer DANAHER CORP NYSE 233,323.682 66.474 40.777 5.8065 0.219
Global Peer ABBOTT LABORATORIES NYSE 226,394.169 50.614 31.391 6.5770 1.197
Global Peer MEDTRONIC PLC NYSE 148,311.161 41.129 38.195 2.8806 2.105
Global Peer INTUITIVE SURGICAL INC NASDAQ 119,492.807 112.665 70.739 10.4718 -
Global Peer STRYKER CORP NYSE 91,857.940 57.447 48.346 6.4789 0.964
Global Peer BECTON DICKINSON & CO NYSE 69,191.087 34.561 34.561 2.9223 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 69,120.017 83.944 46.788 12.4737 -
Global Peer DEXCOM INC NASDAQ 55,343.431 112.122 104.560 25.9086 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 54,990.364 - 52.774 3.3404 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), PERKINELMER INC (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), COOPER COS INC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), NOVOCURE LTD (NASDAQ), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), MICROPORT SCIENTIFIC CORPORATION (HKEx), ANGELALIGN TECHNOLOGY INC (HKEx), SHANGHAI MICROPORT MEDBOT (GROUP) C (HKEx), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INMODE LTD (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), SOTERA HEALTH CO (NASDAQ), QUIDEL CORP (NASDAQ), STEVANATO GROUP S.P.A. (NYSE), TOPGLOV (Bursa), Top Glove (SGX), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), NEVRO CORP (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), AXONICS INC (NASDAQ), HAEMONETICS CORP (NYSE), NUVASIVE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), CAREDX INC (NASDAQ), GLAUKOS CORPORATION (NYSE), LANTHEUS HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CUE HEALTH INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), VICARIOUS SURGICAL INC (NYSE), PARAGON 28 INC (NYSE), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), SILK ROAD MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), PEIJIA MEDICAL LIMITED (HKEx), KANGJI MEDICAL HLDGS LTD (HKEx), ATRION CORP (NASDAQ), SUPERMX (Bursa), BUTTERFLY NETWORK INC (NYSE), PULMONX CORPORATION (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), LEMAITRE VASCULAR INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), VIEWRAY INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), AK MEDICAL HLDGS LTD (HKEx), NANO-X IMAGING LTD (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOVENTUS INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), SISRAM MEDICAL LTD (HKEx), INTERCURE LTD (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), INOGEN INC (NASDAQ), CRYOLIFE INC (NYSE), CUTERA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SI BONE INC (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), SEMLER SCIENTIFIC INC (NASDAQ), 908 DEVICES INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), DERMTECH INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANTARES PHARMA INC (NASDAQ), VAPOTHERM INC (NYSE), IRADIMED CORP (NASDAQ), NYXOAH SA (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), UTAH MEDICAL PRODUCTS (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), AXOGEN INC (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), FLUIDIGM CORP DEL (NASDAQ), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), PAVMED INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), SONENDO INC (NYSE), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), LUCIRA HEALTH INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CVRX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), SIENTRA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), EARGO INC (NASDAQ), ONCOCYTE CORP (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), QUOTIENT LTD (NASDAQ), CYTOSORBENTS CORP (NASDAQ), Medtecs Intl (SGX), UGHealthcare (SGX), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), MINERVA SURGICAL INC (NASDAQ), TELA BIO INC (NASDAQ), CONFORMIS INC (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), INTRICOM CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), FONAR CORP (NASDAQ), INVACARE CORP (NYSE), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), NEURONETICS INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), IRIDEX CORP (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), RGTBHD (Bursa), ALPHA PRO TECH (NYSE American), ELECTROMED INC (NYSE American), KELFRED HOLDINGS LTD (HKEx), ACUTUS MEDICAL INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), REWALK ROBOTICS LTD (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), LENSAR INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), ENVVENO MED CORP (NASDAQ), BIOMERICA INC (NASDAQ), CELSION CORPORATION (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), ADVENTA (Bursa), ELECTROCORE INC (NASDAQ), NUTRIBAND INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), NEUROMETRIX INC (NASDAQ), APPLIED UV INC (NASDAQ), DAXOR CORP (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), Biolidics (SGX), AETHLON MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), KEWAUNEE SCIENTIFIC CORP (NASDAQ), Yunnan Energy (SGX), TIVIC HEALTH SYSTEMS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), HEARTBEAM INC (NASDAQ), INSPIREMD INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), PETVIVO HLDGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), PLUS THERAPEUTICS INC (NASDAQ), LKL (Bursa), SINTX TECHNOLOGIES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), XTANT MEDICAL HLDGS INC (NYSE American), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.